RKIP is widely expressed in normal human tissues, highlighting its role in various physiologic processes [16], but is considered to be a metastasis suppressor in cancer [17], being its loss or reduced expression associated with malignancy and prognosis in many types of metastatic and aggressive cancers [10], [11], [18]–[34]. Here, PEBP1 is linked to cancer.